MRI-based prostate cancer screening follow-up
Part of Cancer, Kidney & urinary clinical trials.
This study is a follow-up for men already in the VISIONING prostate cancer screening program. It uses MRI scans to check for prostate cancer over 5 more years, helping catch any changes early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man who wants to be screened for prostate cancer.
- You have never had a prostate biopsy before.
- You are expected to live more than 10 more years.
- You must have already taken part in the VISIONING study.
- Your prostate must not be too large (less than 80 milliliters).
- You must not have a current urinary tract infection.
- Your urinary symptoms must not be severe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
This study uses special prostate MRI scans to see how prostate cancer changes over time while you stay on active surveillance. It also looks at prostate tissue to understand your cancer’s genetics, which may help guide future decisions.
This study tests a new MRI platform to better identify prostate issues before a biopsy. It is for people with elevated PSA whose doctor is considering a biopsy.
This trial tests whether having repeated MRI scans can help find prostate cancer early in men who have never had a biopsy. It may be a good fit if you have a slightly elevated PSA and a suspicious spot on your first MRI.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.